WHO chief warns against vaccine nationalism

▴ who-chief-warns-against-vaccine-nationalism
WHO on COVID-19 vaccine and nations approach towards it

The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said on Tuesday that the world needs to prevent vaccine nationalism to guarantee the equitable access and fair allocation of COVID-19 vaccines.

Speaking at a virtual press briefing from Geneva, the WHO head said that once a successful vaccine has been identified, WHO's the strategic advisory group will provide recommendations for their appropriate and fair use.

He told reporters that the allocation of vaccines is proposed to be rolled out in two phases.

In phase 1, he said, doses will be allocated proportionally to all countries participating in the WHO-led vaccine development plan simultaneously to reduce the overall risk.

And in phase 2, consideration will be given to countries to threat and vulnerability.

"For most countries, a phase 1 allocation that builds up to 20 percent of the population would cover most of the at-risk groups," he said.

The WHO chief stressed that only when those highest-risk people from the virus everywhere and at the same time are protected, then the world can stabilize health systems and rebuild the global economy.

"Like an orchestra, we need all instruments to be played in harmony to create music that everyone enjoys," he said.

Tags : #WHO #Vaccine #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024